Quantitative ultrastructural characteristics of platelets in the patients with diabetes mellitus type 2 in a compensation with arterial hypertension under correction of arterial blood pressure with losartan.

Authors

  • N. O. Pertseva ДЗ «Дніпропетровська медична академія МОЗ України», Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2011.4.37-44

Keywords:

diabetes mellitus type 2, compensation, arterial hypertension, platelets ultrastructure, losartan

Abstract

We have conducted a quantitative evaluation of ultrastructural changes in the dynamics of platelets in the patients with diabetes mellitus type 2 in a compensation phase with arterial hypertension under correction of arterial blood pressure with losartan and with considering of microalbuminuria. It is shown that in the patients with normalbuminuria observed moderate degree violations of thrombocyte hemostasis, as a result of this is a significant increase in the relative amount of activated platelets with preservation of normal content aggregated and degranulated forms and the appearance of single platelets with an imbalance of alpha and delta granules.Losartan usage makes it possible to normalize ultrastructural disorders of platelets ranging from the 6th month of the treatment. In the patients with microalbuminuria showed a significant damage of thrombocyte hemostasis due to significant growth in the content of the activated, degranulated and aggregated forms of platelets and development of hyperactivation ofplateletsbyhyalinetype. The standard treatment for one year is accompanied by increasing imbalance of granulomer of most platelets and the degree of the heteromorphic pool with a significant increase in aggregate form. Inclusion of losartan in the treatment leads to a substantial reduction of pathomorphological changes of platelets, limitation of their hyperactivity and prevents the formation of giant spherical pseudopodial forms from the 6th month of starting treatment.

References

  1. Зимин Ю. В. Артериальная гипертония при сахарном диабете: особенности патогенеза и лечения (обзор) / Ю. В. Зимин // Тер. архив. – 1999. - № 10. – С. 15-20.
  2. Миронов А. А. Методы электронной микроскопии в биологии и медицине: Методическое руководство / А. А. Миронов, Я. Ю. Комиссарчик, В. А. Миронов. – СПб. : Наука, 1994. – 400 с.
  3. Полифункциональность тромбоцитов, их активация и возможности ее оценки / Л. И. Бурячковская, И. А. Учитель, А. Б. Сумароков [и др.] // Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А. Н. Бакулева РАМН. – 2007. – Т. 8, № 2. – С. 43-50.
  4. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus / F. Carmassi, M. Morale, R. Puccetti [et al.] // Thromb. Res. – 1992. – Vol. 67. – P. 643-654.
  5. Epstein M. Diabetes and hypertension: the bad companions / M. Epstein // J. of Hypertension. – 1997. – Vol. 15, Suppl. 2. – P. 55-62.
  6. Generation of trombin activity in relation to factor VIII: concentrations and vascular complications in type I (insulin-dependent) diabetes mellitus / S. H. Ibbotson, D. Wairnsley, J. A. Davis [et al.] // Diabetologia. – 1992. – Vol.35. – P. 863-867.
  7. Leukocyte-platelet aggregates as a marker of inflammation / L. Bouriachkovskaia, I. Uchitel, N. Dovlatova [et al.] // Platelets. – 2004. – Vol. 16, № 8. – P. 483-484.
  8. Platelet activation and biochemical markers of inflammation in patients with CHD and depression / L. Buriachkovskaia, E. Poliakova, A. Zorin [ et al.] // Atherosclerosis. – 2006. – Vol. 7, № 3. – P. 283-285.
  9. Sawatzke C. L. Fixation and embedding of small volumes of platelets for transmission electron microscopy / C. L. Sawatzke, C. C. Solomons // J. Clin. Pathol. – 1980. – Vol. 33, № 6. – P. 600-602.
  10. Weyrich A. Platelets: signaling cells in the immune continuum / A. Weyrich, G. Zimmerman // Trends in Immunology. – 2004. – Vol. 25, № 9. – P. 489-495.

How to Cite

Pertseva, N. O. (2011). Quantitative ultrastructural characteristics of platelets in the patients with diabetes mellitus type 2 in a compensation with arterial hypertension under correction of arterial blood pressure with losartan. Морфологія / Morphologia / Morfologìâ, 5(4), 37–44. https://doi.org/10.26641/1997-9665.2011.4.37-44

Issue

Section

Статті